EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The impact of colchicine on patients with acute and chronic coronary artery disease

Mehdi Madanchi, Mabelle Young, Gregorio Tersalvi, Giacomo Maria Cioffi, Adrian Attinger-Toller, Florim Cuculi, Reto Kurmann, Matthias Bossard

European Journal of Internal Medicine · 2024

DOI: 10.1016/j.ejim.2024.01.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Internal Medicine, 2024. Verfasst von Mehdi Madanchi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Division, Heart Center, Luzerner Kantonsspital, Spitalstrasse 16, 6000 Lucerne, Switzerland. Hauptthemen laut MEDLINE: Colchicine, Coronary Artery Disease, Anti-Inflammatory Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation plays a central role in coronary artery disease (CAD), and recent data have shown that anti-inflammatory drugs have the potential to reduce ischemic events in CAD patients. Colchicine is an ancient anti-inflammatory drug that targets neutrophil and inflammasome activities. It has been prescribed for decades for different rheumatological conditions. Given the important role of inflammation in the development of cardiovascular disease, there has been considerable interest in studying colchicine's potential to limit the progression of atherosclerosis among afflicted patients. In fact, there is a growing body of randomized data suggesting that use of low-dose colchicine reduces the risk of ischemic events in patients with CAD, particularly repeated revascularizations, new myocardial infarctions and strokes. This review article summarizes background information-including possible side effects and contraindications-as well as the current evidence backing up the use of colchicine in patients with established CAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineCoronary Artery DiseaseAnti-Inflammatory AgentsHumansRandomized Controlled Trials as TopicChronic DiseaseInflammationMyocardial InfarctionAcute Disease

Stichwörter der Autor:innen

ColchicineCoronary artery diseaseInflammationMyocardial infarctionSystematic review

Substanzen

ColchicineAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Cardiology Division, Heart Center, Luzerner Kantonsspital, Spitalstrasse 16, 6000 Lucerne, Switzerland.
  • Cardiology Division, Heart Center, Luzerner Kantonsspital, Spitalstrasse 16, 6000 Lucerne, Switzerland; Department of Cardiovascular Diseases, Mayo Clinic Rochester, MN, USA.
  • Cardiology Division, Heart Center, Luzerner Kantonsspital, Spitalstrasse 16, 6000 Lucerne, Switzerland. Electronic address: matthias.bossard@luks.ch.

Zitieren

APA

Madanchi, M., Young, M., Tersalvi, G., Maria Cioffi, G., Attinger-Toller, A., Cuculi, F., Kurmann, R., & Bossard, M. (2024). The impact of colchicine on patients with acute and chronic coronary artery disease. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2024.01.004

Vancouver

Madanchi M, Young M, Tersalvi G, Maria Cioffi G, Attinger-Toller A, Cuculi F, et al. The impact of colchicine on patients with acute and chronic coronary artery disease. European Journal of Internal Medicine. 2024. doi:10.1016/j.ejim.2024.01.004

BibTeX
@article{Madanchi2024,
  author = {Madanchi, Mehdi and Young, Mabelle and Tersalvi, Gregorio and Maria Cioffi, Giacomo and Attinger-Toller, Adrian and Cuculi, Florim and Kurmann, Reto and Bossard, Matthias},
  title = {The impact of colchicine on patients with acute and chronic coronary artery disease},
  journal = {European Journal of Internal Medicine},
  year = {2024},
  doi = {10.1016/j.ejim.2024.01.004}
}
Kostenlos starten →